$410.39 0.00 (%) Regeneron Pharmaceuticals Inc - NASDAQ

Sep. 23, 2016 | 04:00 PM

Partner Headlines

  1. Biotech ETFs Lead Q3 Rally: XBI Breaks Out

    TalkMarkets | Sep. 22, 2016 | 21:00PM EST
  2. Regeneron Stock Dips As Earnings Beat And Revenue Lags

    Investors Business Daily | Aug. 4, 2016 | 10:44AM EST
  3. Lilly, J&J, Novo Battle For Diabetes Market Heats Up; FDA Rulings Loom

    Investors Business Daily | Jul. 22, 2016 | 10:44AM EST
  4. Benzinga's Top Upgrades

    Benzinga | Feb. 16, 2016 | 08:57AM EST
  5. Biotech Stocks Slip As Hugely Popular Momentum ETF Makes A Big Change

    IBD | Feb. 9, 2016 | 12:41PM EST
  6. Regeneron Q4 Earnings Miss Estimates Amid Slow Praluent Launch

    IBD | Feb. 9, 2016 | 11:28AM EST
  7. Stock Futures Quietly Lower; Yamana Gold Continues Rally

    IBD | Feb. 9, 2016 | 08:55AM EST
  8. Why These Five Sector Leaders Became Former Leaders

    IBD | Feb. 8, 2016 | 16:30PM EST
  9. Benzinga's Top Downgrades

    Benzinga | Jan. 25, 2016 | 09:30AM EST
  10. SMR Rating Uncovers Stocks With Top Sales, Margins

    IBD | Jan. 20, 2016 | 16:50PM EST
  11. Medicines Company Spikes On Report Of Possible Sale

    IBD | Jan. 20, 2016 | 12:59PM EST
  12. Walgreens Exec Buys, CVS CEO Sells Amid Market Rout

    IBD | Jan. 15, 2016 | 15:00PM EST
  13. Stocks Reverse Higher To Big Gains; Intel Falls After Q4 Results

    IBD | Jan. 14, 2016 | 16:29PM EST
  14. Drug Stocks Mixed On Guidance Updates

    IBD | Jan. 12, 2016 | 18:45PM EST
  15. Horizon Up; Zoetis Trims EPS

    IBD | Jan. 12, 2016 | 18:40PM EST
  16. US Stock Futures Surge After Jobs Data

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  17. U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation

    Benzinga | Jan. 8, 2016 | 08:50AM EST
  18. Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA

    Benzinga | Jan. 8, 2016 | 04:01AM EST
  19. Gilead Leads 3 Drug Stocks With Top Fundamentals

    IBD | Jan. 7, 2016 | 08:02AM EST
  20. Alphabet, Palo Alto Networks Lead Week's Insider Deals

    IBD | Dec. 31, 2015 | 13:59PM EST
  21. The 5 Top-Performing Big-Cap Drug Stocks Of 2015

    IBD | Dec. 30, 2015 | 14:16PM EST
  22. Big Biotech Amgen Facing Pivotal Year In 2016

    IBD | Dec. 17, 2015 | 17:08PM EST
  23. Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection

    Benzinga | Dec. 11, 2015 | 04:13AM EST
  24. GoPro Downgraded, Ambarella PT Cut, Biotechs Are Buys

    IBD | Dec. 4, 2015 | 08:53AM EST
  25. LinkedIn, Palo Alto, Regeneron Profit Estimates Rising

    IBD | Dec. 4, 2015 | 08:02AM EST
  26. Stocks Close Lower; UnitedHealth Backs Its Forecasts

    IBD | Nov. 30, 2015 | 17:10PM EST
  27. Stocks Work Off Losses; Lululemon Further Weakens

    IBD | Nov. 30, 2015 | 15:04PM EST
  28. Stocks Trade Lower At Midday; Cambrex Hits New All-Time High

    IBD | Nov. 30, 2015 | 11:58AM EST
  29. Biotechs Weaken, But These Names Have Bullish Charts

    IBD | Nov. 25, 2015 | 17:19PM EST
  30. Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled

    Benzinga | Nov. 24, 2015 | 04:21AM EST
  31. CVS Makes Amgen New BFF

    IBD | Nov. 23, 2015 | 18:42PM EST
  32. CVS' Amgen Pick 'Raises The Bar' For Regeneron, Sanofi

    IBD | Nov. 23, 2015 | 16:06PM EST
  33. Weekly CFO Sells Highlights: Facebook, Fitbit, Regeneron Pharmaceuticals

    GuruFocus | Nov. 23, 2015 | 11:03AM EST
  34. Successful Bases Form Above The 50-Day Moving Average

    IBD | Nov. 17, 2015 | 17:50PM EST
  35. Stocks Strengthen In Afternoon; Biotechs Weak

    IBD | Nov. 16, 2015 | 13:27PM EST
  36. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus | Nov. 15, 2015 | 13:10PM EST
  37. Regeneron Tests Buy Point As New Drug Shows Promise

    IBD | Nov. 13, 2015 | 18:24PM EST
  38. Regeneron Recovers From Clinton Biotech Beat Down

    IBD | Nov. 12, 2015 | 11:27AM EST
  39. Gilead, Regeneron Stocks Weather Drug Pricing Furor

    IBD | Nov. 12, 2015 | 08:02AM EST
  40. Stock Futures Climb Toward Open; Facebook, LinkedIn, Alphabet Rise

    IBD | Nov. 11, 2015 | 08:52AM EST
  41. Regeneron, Sanofi Present Positive Results from Pivotal Phase 3 Study of Sarilumab at ACR Annual Meeting

    Benzinga | Nov. 8, 2015 | 08:29AM EST
  42. Regeneron, Allergan Beat Q3

    IBD | Nov. 4, 2015 | 18:42PM EST
  43. The Best-Performing Stocks Among Vanguard Health Care Fund's Holdings

    GuruFocus | Nov. 4, 2015 | 15:42PM EST
  44. Regeneron Q3 Beats Views, But Praluent Launch Slow

    IBD | Nov. 4, 2015 | 15:41PM EST
  45. Stock Futures Gather Momentum; Baxalta, Tesla, Paycom Climb

    IBD | Nov. 4, 2015 | 09:17AM EST
  46. Facebook, Regeneron Lead Top Earnings To Watch Wed.

    IBD | Nov. 3, 2015 | 13:10PM EST
  47. Stocks Rally To Session Highs; Fitbit, Tesla Jump

    IBD | Nov. 2, 2015 | 14:38PM EST
  48. M&A News Fuels More Gains; Celgene, Regeneron Lead Nasdaq 100

    IBD | Nov. 2, 2015 | 13:19PM EST
  49. Facebook, Visa To Carry IBD 50 Earnings To Peak

    IBD | Oct. 31, 2015 | 08:02AM EST
  50. Regeneron Announces EU Approval of EYLEA® (aflibercept) Injection for the Treatment of Visual Impairment Secondary to Myopic Choroidal Neovascularization

    Benzinga | Oct. 30, 2015 | 09:00AM EST
Trading Center